Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Why Do These Matter in CLL: Long-term Data, Side-Effect Management, and Staying Healthy?

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

Recorded on April 28, 2022

Join CLL Society and PlatformQ Health for this on-demand educational session consisting of 3 chapters:

  • Getting Up-to-Speed on New Data
  • Managing Side Effects of BTK Inhibitors: What, When, How, and WhoTips to
  • Stay on the Patient/Caregiver ‘A Game’

Jennifer Woyach, MD, professor at The Ohio State University leads the discussion and is joined by a CLL Patient Advocate Therese Conlin. Real-world patient experiences frame discussions of what long-term research findings on BTK inhibitors and other treatments mean for patient quality of life. Registration is required before viewing the event.